Drdgold annual stock-based compensation
2018
2019
2020
2021
2022
2023
2024
2025
2026
Drdgold Stock-Based Compensation Growth & History (DRD)
Drdgold's stock-based compensation was R41.7M for fiscal 2026.
View full Drdgold company overviewDrdgold annual stock-based compensation history
| Fiscal year | Period ended | Stock-based compensation | Change | Growth |
|---|---|---|---|---|
| 2026 | 2026-06-30 | R41.7M | R11.6M | +38.54% |
| 2025 | 2025-06-30 | R30.1M | R3.7M | +14.02% |
| 2024 | 2024-06-30 | R26.4M | R4.4M | +20.00% |
| 2023 | 2023-06-30 | R22.0M | R3.6M | +19.57% |
| 2022 | 2022-06-30 | R18.4M | −R9.9M | −34.98% |
| 2021 | 2021-06-30 | R28.3M | −R195.8M | −87.37% |
| 2020 | 2020-06-30 | R224.1M | R202.7M | +947.20% |
| 2019 | 2019-06-30 | R21.4M | R4.2M | +24.42% |
| 2018 | 2018-06-30 | R17.2M | — | — |
Drdgold stock-based compensation trends
Over the last five fiscal years, Drdgold's stock-based compensation increased from R28.3M to R41.7M, a change of R13.4M.
About the metric
What stock-based compensation means
Stock-based compensation is the expense associated with equity awards such as restricted stock and employee options. It is a non-cash expense when recognized, but it can dilute existing shareholders unless offset by share repurchases.
Calculation and source
SEC-reported stock-based compensation
TickerStat standardizes share-based compensation reported in company SEC filings. The history shows recognized compensation expense or its cash-flow-statement adjustment, not the grant-date value of new awards or a forecast of future dilution. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Drdgold source filings ↗